Delivery Order SPE2DR25D1022-SPE2DR26FQQ3D
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector units on September 11, 2025, with an ultimate completion date of October 2, 2025. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $3,082.67 and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Benlysta is a biologic medication used to treat systemic lupus erythematosus and lupus nephritis,...
- The Defense Logistics Agency awarded a $9,248.01 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on July 30, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Benlysta is a biologic immunosuppressant used to treat systemic lupus erythematosus and other...
- The Defense Logistics Agency awarded a $3,082.67 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Benlysta 200 mg/ml auto-injector units. This competitive award, utilizing firm fixed pricing with no set-aside designation, is scheduled for completion by August 14, 2025, with fulfillment performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Benlysta is a biologic medication used primarily in the treatment of systemic lupus...
- The Defense Logistics Agency awarded a delivery order valued at $18,496.02 to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injectors. The contract, issued on September 12, 2025, with an ultimate completion date of October 3, 2025, utilizes firm fixed-price pricing with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $18,496.02 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector on September 19, 2025, with an ultimate completion date of October 10, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Benlysta is a specialized biologic medication used primarily in the treatment...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on October 27, 2025, with a ceiling value of $12,330.68 and an ultimate completion date of November 18, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Benlysta is a biologic immunosuppressant medication used to treat systemic lupus...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,987.78 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on May 13, 2025, with completion expected by June 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Benlysta is a biologic medication used to treat systemic lupus erythematosus and lupus nephritis, representing a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Benlysta 200 mg/ml auto-injectors, a biologic medication used to treat systemic lupus erythematosus. This firm fixed-price delivery order carries a ceiling value of $3,248.66 and is scheduled for completion by December 5, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $12,330.68 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injectors on September 18, 2025, with an ultimate completion date of October 9, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. Benlysta (belimumab) is a monoclonal antibody used to treat systemic lupus erythematosus, representing a specialty...
- The Defense Logistics Agency awarded a $6,165.34 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injectors, with a completion date of June 24, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Benlysta is a biologic medication used to treat systemic lupus erythematosus, reflecting the breadth of specialty pharmaceuticals...
- SPE2DR25D1022Indefinite Delivery Contract
- SPE2DR25D1022-SPE2DR26FQQ3DDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,994.64 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector on November 18, 2025, with completion scheduled by December 10, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Benlysta is a prescription biologic medication used primarily in the treatment of systemic lupus erythematosus, reflecting the Defense Logistics Agency's Medical Supply Chain's commitment to providing specialized pharmaceutical products to support military and veteran healthcare needs. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) SPE2DX with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply a broad portfolio of medications and medical supplies—including specialty drugs, vaccines, and medical devices—to support military healthcare programs globally. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen has demonstrated substantial capability in fulfilling federal medical procurement requirements through competitive award processes and serves critical customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.0k | 11/18/25 |